Stockscreener 앱 받기
234.76
2.60%
5.96
시간 외 거래:
237.89
3.13
+1.33%
Natera Inc 주식(NTRA)의 최신 뉴스
Natera (NTRA) Stock Fair Value Edges Lower As MRD And Signatera Debate Splits Analysts - Yahoo Finance
Why Is Natera Stock Gaining Tuesday? - Benzinga
Natera’s Signatera receives NCCN Category 1 recommendation By Investing.com - Investing.com Canada
NCCN Recommends ctDNA-MRD Testing Using Signatera™ Technology in Landmark Bladder Cancer Guideline Update - Business Wire
Natera co-founder Sheena Jonathan sells $329,809 in company stock - Investing.com UK
Signatera (NTRA) Gains Momentum with New NCCN Bladder Cancer Gui - GuruFocus
Form 4 Natera Inc For: 22 June By Investing.com - Investing.com Canada
Natera (NTRA) co-founder’s family trusts sell 1,500 shares under 10b5-1 plan - Stock Titan
Natera co-founder Sheena Jonathan sells $329,809 in company stock By Investing.com - Investing.com Canada
Natera expands Austin operations with new sequencing facility - MSN
Pirche Announces Partnership to Advance Transplant Medicine by Combining Pre-Transplant Risk Stratification and Post-Transplant dd-cfDNA Monitoring - marketscreener.com
Natera IVF Genetic Testing Class Action Lawsuit Claims PGT-A Results Were Misleading - AboutLawsuits.com
Natera (NTRA) Stock Could Be 11.3% Undervalued After Prospera Transplant Data - simplywall.st
Natera StockWeekly review and sector comparison after recent capital raise - AD HOC NEWS
Natera to Showcase Organ Health Leadership with 21 Presentations at the American Transplant Congress - The National Law Review
Natera to present 21 transplant studies, including 7 oral talks - Stock Titan
Natera director Rowan Chapman sells $642,535 in stock By Investing.com - Investing.com Australia
Insider Sell: Rowan Chapman Sells 2,964 Shares of Natera Inc (NT - GuruFocus
Natera Inc (NTRA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Natera co-founder Sheena Jonathan sells $665,087 in shares By Investing.com - Investing.com Nigeria
Natera co-founder Sheena Jonathan sells $665,087 in shares - Investing.com
Natera director Rowan Chapman sells $642,535 in stock - Investing.com
Natera (NTRA) co-founder Sheena Jonathan sells 3,150 shares in 10b5-1 plan trades - Stock Titan
Natera Inc (NTRA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Natera Inc (NTRA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Natera Inc (NTRA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Natera Inc (NTRA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Natera Inc (NTRA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Natera Inc (NTRA) Institutional Confidence - TradingKey
Is Natera’s CytoDyn ctDNA Tie-Up and Board Refresh Reframing the Investment Case for NTRA? - simplywall.st
Natera (NTRA), CytoDyn Announce Strategic Collaboration for ctDNA-Guided mCRC Clinical Trials - Yahoo Finance
Natera executive chairman sells $21.4 million in shares By Investing.com - Investing.com South Africa
Natera executive chairman sells $21.4 million in shares - Investing.com
Executive chairman of Natera (NTRA) sells 100,000 shares in Rule 10b5-1 trades - Stock Titan
Natera shareholders approve equity plan amendment and elect directors at annual meeting - Investing.com UK
Thomas Lynch joins Natera (NASDAQ: NTRA) board as new independent director - Stock Titan
Natera (NASDAQ: NTRA) OKs equity plan share boost and director slate - Stock Titan
[144] Natera, Inc. SEC Filing - Stock Titan
Goldman Sachs Initiates Coverage on Natera, Inc. (NTRA) - Yahoo Finance
Natera, Inc. (NTRA) Stock Analysis: Evaluating a 22.62% Potential Upside in the Diagnostics Arena - DirectorsTalk Interviews
Billionaire Stanley Druckenmiller’s Top Bet: Natera (NTRA) and the Rise of Liquid Biopsy TestingMid-Term Outlook - newsline.com
Natera to launch enhanced Panorama NIPT for low fetal fractions - MSN
Natera Shares Slide Over 3% as Stock Tests Key Support LevelsCharm Flow - newsline.com
Forget SpaceX Hype: Billionaire Stanley Druckenmiller is Loading Up on This Unknown Healthcare Stock - Insider Monkey
Morgan Stanley files Form 144 for 100,000 NTRA shares (NASDAQ: NTRA) - Stock Titan
Natera Inc Stock (US6323071042): Analyst calls from RBC and Goldman put diagnostics specialist in fo - AD HOC NEWS
Natera MRD Leadership Supported by 'Durable' High-Value Market, RBC Says - Moomoo
NTRA & Diakonos partner to use Signatera in refractory melanoma trial - MSN
RBC Capital Maintains Natera(NTRA.US) With Buy Rating, Cuts Target Price to $275 - Moomoo
Natera stock jumps into focus as RBC resumes coverage with Outperform rating and a $275 price target - Business Upturn
RBC Capital initiates Natera stock coverage with outperform rating By Investing.com - Investing.com Australia
RBC Capital initiates Natera stock coverage with outperform rating - Investing.com
Natera (NTRA) Coverage Resumed with Positive Outlook and Price T - GuruFocus
NTRA & CytoDyn partner to advance ctDNA-guided development in mCRC - MSN
0.29%
0.14%
자본화:
|
볼륨(24시간):